Home
DrugRxiv Drug Repurposing Network Medicine
REPO4EU Meet the team Drug Repurposing Research Collection Conference
Blog
Register Dashboard
Search
Home
DrugRxiv Drug Repurposing Network Medicine
REPO4EU Meet the team Drug Repurposing Research Collection Conference
My ScienceOpen

Register Dashboard
Search
20
views
cited by
0
0
comments
 Comment
0
recommends
+1 Recommend
0
shares
    605
    similar
     All similar
    • Review: found
    Is Open Access

    Review of 'Unlocking drug repurposing clinical trials: resources for investigators'

    Reviewer:
    Publication date of review:
    Bookmark
    5
    Unlocking drug repurposing clinical trials: resources for investigatorsCrossref
    Excellent summary of Phase II clinical trial types as used in drug repurposing
    Average rating:
        Rated 5 of 5.
    Level of importance:
        Rated 4 of 5.
    Level of validity:
        Rated 5 of 5.
    Level of completeness:
        Rated 5 of 5.
    Level of comprehensibility:
        Rated 5 of 5.
    Competing interests:
    		None

    Reviewed article

    • Record: found
    • Abstract: found
    • Article: found
    Is Open Access

    Unlocking drug repurposing clinical trials: resources for investigators

    Bridget Peterson (2024)
    Drug repurposing has recently been recognized for its potential to improve the process of drug development. To facilitate the implementation of drug repurposing in clinical research, resources to support investigators in conducting Phase II repurposing trials are under development, which will be presented as part of a comprehensive platform. Innovative clinical trial designs and mechanism-based network pharmacology are also emphasized.
    Article 0 comments Cited 0 times    Rated -3 of 5. – based on 1 reviews
    Preprint Version (Latest)
      Bookmark

      Review information

      DOI:: 10.14293/S2199-1006.1.SOR-LIFE.ANE16N.v1.ROIIZT
      License:
      This work has been published open access under Creative Commons Attribution License CC BY 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com.

      ScienceOpen disciplines: Life sciences
      Keywords: Mechanism-based network pharmacology,Investigator initiated trials,Drug repurposing,Phase II clinical trials,Innovative clinical trial designs

      Review text

      This is a very good top-level summary of what clinical Phase II trials in drug repurposing are, and how REPO4EU uses them to achieve its objectives.. We can publish it in its present version.

      Comments

      Comment on this review

      Version and Review History
      1
      Preprint Version
      Reviewed by Hermann Mucke